|
Market Closed -
NYSE
16:03:10 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 378.88 USD | -0.49% |
|
-2.61% | +47.92% |
| 08-20 | Humana Inc. Announces Appointment of Shantanu Nundy as Chief Medical Officer, Effective August 31, 2026 | CI |
| 08-13 | Humana agrees not to reference Teva's Israel ties at US drug trial | RE |
| Market Cap | 45.5B 38.97B 36.47B 33.38B 62.64B 4,353B 63.47B 431B 168B 2,187B 171B 167B 7,233B | P/E 2026 * |
52.9x | P/E 2027 * | 23.3x |
|---|---|---|---|---|---|
| Enterprise Value | 53B 45.4B 42.48B 38.89B 72.98B 5,071B 73.94B 502B 196B 2,548B 199B 195B 8,426B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.31x |
| Free-Float |
60.3% | Yield 2026 * |
0.97% | Yield 2027 * | 1% |
Last Transcript: Humana Inc.
| 1 day | -0.49% | ||
| 1 week | -2.61% | ||
| Current month | +4.13% | ||
| 1 month | -6.30% | ||
| 3 months | +24.76% | ||
| 6 months | +99.59% | ||
| Current year | +47.92% |
| 1 week | 371.5 |  | 392.52 |
| 1 month | 353.69 | | 399.61 |
| Current year | 163.11 | | 428.88 |
| 1 year | 163.11 | | 428.88 |
| 3 years | 163.11 | | 530.54 |
| 5 years | 163.11 | | 571.3 |
| 10 years | 163.11 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Celeste Brown
DFI | Director of Finance/CFO | 49 | 2025-01-10 |
Bobby Mukundan
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 65 | 2013-12-31 |
Frank D'Amelio
BRD | Director/Board Member | 68 | 2003-08-31 |
Karen Katz
BRD | Director/Board Member | 69 | 2019-09-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/1/26 | Other | Director | 544 | 0.0005% | ||
| 8/1/26 | Free | Director | 544 | 0.0005% | ||
| 7/28/26 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.49% | -2.61% | +28.67% | -22.88% | 45.5B | |
| +1.37% | -2.89% | +28.60% | -21.61% | 350B | |
| +1.07% | +0.05% | +29.37% | -14.10% | 86.86B | |
| +1.13% | -1.79% | -7.79% | -1.33% | 73.33B | |
| +1.37% | -3.63% | +125.69% | +1.86% | 32.12B | |
| +1.70% | -5.71% | +15.89% | -37.41% | 10.43B | |
| +1.78% | -5.73% | -16.71% | +113.64% | 2.73B | |
| +1.22% | -9.78% | +59.00% | +212.03% | 2.2B | |
| -1.19% | -2.40% | +10.89% | -31.71% | 1.97B | |
| +1.36% | +3.46% | -33.78% | - | 282M | |
| Average | +0.93% | -2.82% | +23.98% | +22.05% | 60.56B | |
| Weighted average by Cap. | +1.16% | -2.33% | +29.06% | -15.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 163B 139B 130B 119B 224B 15,571B 227B 1,541B 601B 7,822B 611B 598B 25,871B | 169B 145B 135B 124B 232B 16,144B 235B 1,598B 623B 8,110B 634B 620B 26,824B |
| Net income | 886M 759M 710M 650M 1.22B 84.76B 1.24B 8.39B 3.27B 42.58B 3.33B 3.25B 141B | 2.02B 1.73B 1.62B 1.48B 2.78B 193B 2.81B 19.1B 7.45B 96.94B 7.57B 7.41B 321B |
| Net Debt | 7.51B 6.43B 6.02B 5.51B 10.34B 718B 10.47B 71.08B 27.72B 361B 28.19B 27.57B 1,193B | 6.41B 5.49B 5.14B 4.7B 8.83B 613B 8.94B 60.7B 23.67B 308B 24.07B 23.55B 1,019B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$378.88 | -0.49% | 1,143,637 |
| 26-08-20 | US$380.73 | +0.72% | 1,316,616 |
| 26-08-19 | US$378.02 | -1.04% | 1,141,349 |
| 26-08-18 | US$382.00 | -0.60% | 741,194 |
| 26-08-17 | US$384.31 | -1.22% | 756,587 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
